Viracta Therapeutics (VIRX) Q2 2023 Earnings

Aug 14Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-0.47
-0.4
-0.34
-0.27

Details

Expected EPS
-0.28
Actual EPS
-0.32
Surprise EPS
-0.04
Surprise Percent
-14.29%

Description

⁨Viracta Therapeutics⁩ (⁦VIRX⁩) has reported earnings of ⁦-0.32⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts